IMMUNITYBIO, INC. (IBRX) Share buybacks
- Total buybacks · last 12 months (USD): Value $0.00; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2021-12-31..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2021-12-31..
Share buybacks
Overview →Financial period ending 2021-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $0.00 | Trailing-year cash paid for share repurchases. Period ending 2021-12-31. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 0.00 USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2021-12-31 | $0.00 | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2020-09-30 | $0.00 | (m) | (m) |
| 2020-06-30 | $0.00 | (m) | (m) |
| 2019-12-31 | $501.00K | (m) | (m) |
| 2019-09-30 | $729.00K | (m) | (m) |
| 2019-06-30 | $729.00K | (m) | (m) |
| 2018-12-31 | $228.00K | (m) | (m) |
| 2018-09-30 | $2.77M | (m) | (m) |
| 2018-06-30 | $2.77M | (m) | (m) |
| 2018-03-31 | $14.18M | (m) | (m) |
| 2017-12-31 | $15.23M | (m) | (m) |
| 2017-09-30 | $16.41M | (m) | (m) |
| 2017-06-30 | $18.98M | (m) | (m) |
| 2017-03-31 | $14.35M | (m) | (m) |
| 2016-12-31 | $15.85M | (m) | (m) |
| 2016-09-30 | $11.90M | (m) | (m) |
| 2016-06-30 | $9.32M | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) |
| 2015-12-31 | $4.80M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |